There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
"Kasichayanula; S, et al,: Diabetes; Obesity and Metabolism 13; 47 (2011); Lin; T,; et al,: Bioorgan, Med, Chem,; 21; 6282 (2013); Rajan; S,; et al,: Process for the preparation of (1S)-1;5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol (dapagliflozin) and its solvate thereof; Indian Patent 2014CH01141; Sep 11; 2015;"
Synonyms
-
Application Notes
Impurity in commercial preparations of Dapagliflozin.
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information.
Overview
Impurity in commercial preparations of Dapagliflozin.
